Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

R. P. Scherer

This article was originally published in The Tan Sheet

Executive Summary

Janssen Pharmaceutica launches Imodium Lingual -- a loperamide tablet using Scherer's Zydis fast-dissolving dosage form -- in Germany. Scherer noted that the dosage form dissolves on the tongue and does not require water to aid swallowing. Zydis has previously been used in Glaxo's Rx anti-emetic Zofran.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel